[HTML] frontiersin.org

[HTML][HTML] Pretreatment neutrophil-to-lymphocyte ratio as a prognostic biomarker in unresectable or metastatic esophageal cancer patients with anti-PD-1 therapy

Y Gao, Z Zhang, Y Li, S Chen, J Lu, L Wu, Z Ma… - Frontiers in …, 2022 - frontiersin.org
Background The neutrophil-to-lymphocyte ratio (NLR) is an inflammatory index calculated
by the absolute neutrophil count dividing the absolute lymphocyte count, and its prognostic …
被引用次数：15 相关文章

[引用][C] Pretreatment Neutrophil-to-Lymphocyte Ratio as a Prognostic Biomarker in Unresectable or Metastatic Esophageal Cancer Patients With Anti-PD-1 Therapy

Y Gao, Z Zhang, Y Li, S Chen, J Lu, L Wu… - Frontiers in Oncology …, 2022 - jglobal.jst.go.jp
Pretreatment Neutrophil-to-Lymphocyte Ratio as a Prognostic Biomarker in Unresectable or
Metastatic Esophageal Cancer Patients With Anti-PD-1 Therapy | Article Information | J-GLOBAL …

Pretreatment Neutrophil-to-Lymphocyte Ratio as a Prognostic Biomarker in Unresectable or Metastatic Esophageal Cancer Patients With Anti-PD-1 Therapy

Y Gao, Z Zhang, Y Li, S Chen, J Lu… - Frontiers in …, 2022 - pubmed.ncbi.nlm.nih.gov
Background The neutrophil-to-lymphocyte ratio (NLR) is an inflammatory index calculated
by the absolute neutrophil count dividing the absolute lymphocyte count, and its prognostic …

Pretreatment Neutrophil-to-Lymphocyte Ratio as a Prognostic Biomarker in Unresectable or Metastatic Esophageal Cancer Patients With Anti-PD-1 Therapy

Y Gao, Z Zhang, Y Li, S Chen, J Lu, L Wu, Z Ma… - Frontiers in …, 2022 - cir.nii.ac.jp
抄録< jats: sec>< jats: title> Background</jats: title>< jats: p> The neutrophil-to-lymphocyte
ratio (NLR) is an inflammatory index calculated by the absolute neutrophil count dividing the …

Pretreatment Neutrophil-to-Lymphocyte Ratio as a Prognostic Biomarker in Unresectable or Metastatic Esophageal Cancer Patients With Anti-PD-1 Therapy.

Y Gao, Z Zhang, Y Li, S Chen, J Lu, L Wu, Z Ma… - Frontiers in …, 2022 - europepmc.org
Background The neutrophil-to-lymphocyte ratio (NLR) is an inflammatory index calculated
by the absolute neutrophil count dividing the absolute lymphocyte count, and its prognostic …
[HTML] nih.gov

[HTML][HTML] Pretreatment Neutrophil-to-Lymphocyte Ratio as a Prognostic Biomarker in Unresectable or Metastatic Esophageal Cancer Patients With Anti-PD-1 Therapy

Y Gao, Z Zhang, Y Li, S Chen, J Lu, L Wu… - Frontiers in …, 2022 - ncbi.nlm.nih.gov
Background The neutrophil-to-lymphocyte ratio (NLR) is an inflammatory index calculated
by the absolute neutrophil count dividing the absolute lymphocyte count, and its prognostic …